Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 2
2018 5
2021 1
2022 8
2023 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: sarjoeeye
Page 1
Journal Club Review of "Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody-Associated Vasculitis: Systematic Review and Meta-Analysis".
Elfishawi M. Elfishawi M. ACR Open Rheumatol. 2022 May;4(5):406-409. doi: 10.1002/acr2.11409. Epub 2022 Feb 4. ACR Open Rheumatol. 2022. PMID: 35119219 Free PMC article.
OBJECTIVE: The objective of this study was to compare the efficacy and safety of two rituximab (RTX) regimens for the induction of remission in severe antineutrophil cytoplasm antibody-associated vasculitis (AAV): the four-dose (375 mg/m(2) intravenously weekly) versus the …
OBJECTIVE: The objective of this study was to compare the efficacy and safety of two rituximab (RTX) regimens for the induction of remission …
Assessment of Tolerability, Response and Complications of Concurrent Chemoradiation With Capecitabine and Cisplatin in Muscle-Invasive Bladder Cancer; A Single Arm Study.
Soltanzadeh S, Saeedian A, Ghalehtaki R, Ayati M, Nowroozi M, Haddad P, Sabet MS, Kheirolahi A. Soltanzadeh S, et al. Clin Genitourin Cancer. 2023 Feb;21(1):105.e1-105.e6. doi: 10.1016/j.clgc.2022.07.007. Epub 2022 Jul 19. Clin Genitourin Cancer. 2023. PMID: 35948483 Clinical Trial.
After maximal TURBT, 66Gy/33 daily fractions of radiation were administered with concurrent chemotherapy of cisplatin (35 mg/m(2)) and capecitabine (625 mg/m(2)). The primary endpoint was treatment tolerability, defined as receiving capecitabine+cisplatin combinatio …
After maximal TURBT, 66Gy/33 daily fractions of radiation were administered with concurrent chemotherapy of cisplatin (35 mg/m(2)) an …
17 results